Tom Mac Mahon
Andrew brings significant experience in neurosurgery,
technology development, and company building to Foundation Medical Partners.
Prior to joining the firm, he was a venture partner at Sprout Group and managing
director of its healthcare technology spinout, New Leaf Venture Partners, and
previously, a principal at Canaan Partners. Andrew has led numerous venture
capital investments and has helped many early stage companies become successful
market leaders. He was a founder (and invented the core technology) of Northstar
Neuroscience, which went public in 2006 (NASDAQ: NSTR) and was subsequently
acquired by St. Jude Medical (NYSE: STJ). He also served as chairman of IntElect
Medical, which was acquired by Boston Scientific (NYSE: BSX).
Representative investments include BridgePoint Medical (acquired by Boston
Scientific Corporation, NYSE: BSX), Explorys, Functional Neuromodulation, i1
Biometrics, Predilytics, SetPoint Medical, Spine Wave, Vertos Medical, and
Visiogen (acquired by Abbott, NYSE: ABT).
During more than a decade in
the healthcare profession, he published more than 50 medical articles, wrote
chapters for several medical textbooks, and was co-editor of a book about
cerebrovascular surgery. His scientific work has been presented at many
international conferences and he holds numerous patents for his inventions. As a
board certified neurosurgeon, he served as clinical assistant professor of
neurosurgery at the New York University School of Medicine. He is a member of
the Innovation Advisory Board at the Cleveland Clinic and the Cornell Biomedical
Engineering Advisory Council, and has served on the Cornell University Council
as chairman of the Technology Transfer Committee and member of the Life Sciences
Andrew earned his M.D. from Cornell University Medical
College and his M.B.A. from the University of Pittsburgh after studying biology
at Cornell and Oxford University.